Penn Medicine 2020 Updates in Oncology
Video Player is loading.
10 seconds
Playback speed
2020 ASCO GI Cancer Update: Is There a Difference in Survival With FOLFIRINOX vs. Gemcitabine and Abraxane in Pancreatic Adenocarcinoma? Did FGFRi Pemigatinib Show PFS in Cholangiocarcinomas? Do IO Combinations Improve OS vs. Sorafenib in HCC?
By
Penn Medicine 2020 Updates in Oncology
FEATURING
Jennifer Eads
By
Penn Medicine 2020 Updates in Oncology
FEATURING
Jennifer Eads
Comments 0
Login to view comments.
Click here to Login
